8 pending office actions • 3 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Genentech, Inc. | 4 |
| Hoffmann-La Roche, Inc. | 3 |
| Hoffmann-La Roche, Inc. | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18743437 | PROGNOSTIC MODELS FOR PREDICTING FIBROSIS DEVELOPMENT | Hoffmann-La Roche, Inc. | YENTRAPATI, AVINASH | 2672 | Non-Final OA | Jun 14, 2024 |
| 18744107 | PREDICTING OPTIMAL TREATMENT REGIMEN FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) PATIENTS USING MACHINE LEARNING | Hoffmann-La Roche, Inc. | JACKSON, JORDAN L | 2857 | Final Rejection | Jun 14, 2024 |
| 18536174 | HIERARCHICAL WORKFLOW FOR GENERATING ANNOTATED TRAINING DATA FOR MACHINE LEARNING ENABLED IMAGE SEGMENTATION | Genentech, Inc. | TSAI, TSUNG YIN | 2656 | Non-Final OA | Dec 11, 2023 |
| 18482237 | TREATMENT OUTCOME PREDICTION FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION USING BASELINE CHARACTERISTICS | Genentech, Inc. | WINDSOR, COURTNEY J | 2661 | Final Rejection | Oct 06, 2023 |
| 18482264 | MACHINE LEARNING-BASED PREDICTION OF TREATMENT REQUIREMENTS FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) | Hoffmann-La Roche, Inc. | SORRIN, AARON JOSEPH | 2672 | Non-Final OA | Oct 06, 2023 |
| 18328305 | MULTIMODAL PREDICTION OF GEOGRAPHIC ATROPHY GROWTH RATE | Genentech, Inc. | BITAR, NANCY | 2664 | Non-Final OA | Jun 02, 2023 |
| 18328296 | MULTIMODAL PREDICTION OF VISUAL ACUITY RESPONSE | Hoffmann-La Roche, Inc. | GORADIA, SHEFALI DINESH | 2676 | Non-Final OA | Jun 02, 2023 |
| 17806252 | INHALER DEVICES, MEDICATION FORMULATIONS USED THEREWITH AND METHODS OF MANUFACTURE | Genentech, Inc. | RUDDIE, ELLIOT S | 3785 | Non-Final OA | Jun 09, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial